Sampirtine

Sampirtine

SCHEMBL29973209

Nc1ccc(Cc2ccc(F)cc2)c(N)n1

nearest known ligand 0.62

Full drug profile on Sugi Atlas →

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
MPO P05164 1/20 0.49
IDO1 P14902 1/20 0.40
BACE1 P56817 1/20 0.40
LOXL2 Q9Y4K0 1/20 0.40
ADCY10 Q96PN6 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sampirtine SCHEMBL1230637 1.00 MPO (0.49) MPOIDO1BACE1LOXL2ADCY10
Sampirtine SCHEMBL10569152 0.98 MPO (0.48) MPOIDO1BACE1LOXL2ADCY10
Sampirtine SCHEMBL10569379 0.86 KDM4E (0.42) MPO
SCHEMBL21223703 0.81 MPO (0.49) MPOADCY10
SCHEMBL57463 0.80 MPO (0.56) MPOADCY10
SCHEMBL21223649 0.80 CYP3A4 (0.46) MPO
SCHEMBL10569673 0.79 MPO (0.55) MPOIDO1ADCY10
Hydrochloric Acid SCHEMBL21223749 0.78 CYP3A4 (0.45) MPO
Hydrochloric Acid SCHEMBL10569158 0.78 MPO (0.53) MPOIDO1ADCY10
SCHEMBL10573978 0.73 MPO (0.51) MPOIDO1ADCY10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4081199-A2 LIPOXYGENASE INHIBITORS SRI International (US) 2022-11-02 EP disclosed
CN-115135316-A Lipoxygenase inhibitors 思研(SRI)国际顾问与咨询公司 2022-09-30 CN disclosed